VANCOUVER, British Columbia, July 6, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery, is pleased to announce that it has appointed Dr. Lola Maksumova, MD, Ph.D. as Senior Vice President and Chief Operating Officer.
